Description
Ellansé M is an innovative tissue biostimulator designed to stimulate the skin’s natural collagen production. The product is composed of 70% carboxymethylcellulose, responsible for the immediate filling effect, and 30% polycaprolactone (PCL) microspheres – a medical polymer with a high safety profile. The smooth PCL particles, measuring over 20 µm, become encapsulated within the tissue, creating a scaffold for type I collagen fibers. As a result, the skin gains density, elasticity, and a rejuvenated appearance.
Immediately after the procedure, a visible filling effect can be observed, while in the following months, collagen biostimulation gradually increases, making the results more natural and long-lasting. The product fully integrates with the extracellular matrix, making it undetectable under the skin and allowing facial expressions to remain unaffected. Ellansé is safe, completely biodegradable, and does not cause allergic reactions or granulomas.
Indications:
- Deep nasolabial folds
- Marionette lines
- Horizontal and vertical forehead wrinkles
- Perioral lines (“smoker’s lines”)
- Drooping corners of the mouth
- Crow’s feet
- Tear trough correction
- Atrophic scars, including acne scars
- Cheek and chin augmentation and contouring
- Improvement of facial oval
- Skin firming
Duration of results:
Depending on the product variant, results last between 12 and 48 months:
- Ellansé™ S – approx. 1 year
- Ellansé™ M – approx. 2 years
- Ellansé™ L – approx. 3 years
- Ellansé™ E – approx. 4 years
Composition:
- Polycaprolactone (PCL) – fully bioresorbable medical polymer
- Carboxymethylcellulose (USP) – carrier for PCL
Administration:
The product is administered subcutaneously in areas requiring correction, most commonly with a 27G x 20 mm needle. The recommended technique is linear threading while withdrawing the needle.
Packaging:
2 pre-filled syringes of 1 ml each.
For professional use only.
By purchasing this product, you declare that you are a physician or an aesthetic practitioner trained in aesthetic medicine.
